Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio
Psilera, Inc. ("Psilera"), a biotechnology company developing groundbreaking therapies for hard-to-treat neurological ...
Psychedelic: Exclusive talk with biotech company Enveric Biosciences
In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...
'Ferryman' in the brain transports souls into the afterlife
The 'ferryman' that transports souls to the afterlife in Greek mythology may actually be a psychedelic neurochemical in the ...
A Psychedelic Molecule Controls Your Consciousness at the Moment of Death, New Theory Suggests
Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...
Cantor Fitzgerald Forecasts GH Research FY2024 Earnings
Research analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of GH Research in a report released on ...
pharmaphorum1 天
Consolidation in psychedelics starts as Beckley and Eleusis combine
Eleusis' drug will slot into Beckley's pipeline alongside lead drug BPL-003, an intranasal formulation of psychoactive compound 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) heading for phase 2 ...
pharmaphorum4 天
Beckley Psytech raises $80m for psychedelic meds development
The money is also earmarked for a phase 1 dose-ranging study on an intranasal formulation of 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a psychedelic compound found in plants and at least one ...
GH Research (NASDAQ:GHRS) Now Covered by Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of GH Research (NASDAQ:GHRS – Free Report) in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The firm issued an ...